Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's

Valneva /zigman2/quotes/202377434/delayed FR:VLA -1.62% shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's /zigman2/quotes/203048482/delayed UK:AZN -1.09% in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.

/zigman2/quotes/202377434/delayed

Add to watchlist FR:VLA

Valneva SE

FR : France: Euronext Paris

€ 28.02

-0.46 -1.62%

Volume: 4.15M

Nov. 30, 2021 5:35p

P/E Ratio

N/A

Dividend Yield

N/A

Market Cap

€2.99 billion

Rev. per Employee

N/A

/zigman2/quotes/203048482/delayed

Add to watchlist UK:AZN

AstraZeneca PLC

UK : U.K.: London

8,276.00 p

-91.00 -1.09%

Volume: 3.66M

Nov. 30, 2021 4:35p

P/E Ratio

88.15

Dividend Yield

2.44%

Market Cap

£129.62 billion

Rev. per Employee

£282,763